K Kiel
About
In The Last Decade
K Kiel
11 papers receiving 311 citations
Peers
Comparison fields: 5 of 43
- Hematology 161
- Molecular Biology 126
- Cellular and Molecular Neuroscience 120
- Electrical and Electronic Engineering 55
- Oncology 51
Countries citing papers authored by K Kiel
This map shows the geographic impact of K Kiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Kiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Kiel more than expected).
Fields of papers citing papers by K Kiel
This network shows the impact of papers produced by K Kiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Kiel. The network helps show where K Kiel may publish in the future.
Co-authorship network of co-authors of K Kiel
This figure shows the co-authorship network connecting the top 25 collaborators of K Kiel. A scholar is included among the top collaborators of K Kiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Kiel. K Kiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 131 | |
| 2 | 7 | |
| 3 | 18 | |
| 4 | 24 | |
| 5 | 31 | |
| 6 | 37 | |
| 7 | 1 | |
| 8 | Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone. | 28 |
| 9 | 25 | |
| 10 | A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cells. | 10 |
| 11 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.